12 November 2020
\n \n \n \nAssociate Professor Neil Herring has been awarded a Senior Clinical Research Fellowship and a Project grant from the British Heart Foundation to further critical research into the mechanisms behind heart attacks and heart failure and potential drugs to combat them. Given the 50% reduction in research investment this year from the BHF due to the impact of COVID-19, Prof Herring is to be congratulated on these awards.
\n \n\n \n \n6 November 2020
\n \n \n \n\n \n \n6 November 2020
\n \n \n \nA hormone which helps regulate bone mass is also produced by the heart and could help treat people with a dangerous heart rhythm disorder, according to a new study published in the journal Nature.
\n \n\n \n \n30 October 2020
\n \n \n \nCongratulations are in order to Pawel Swietach on his conferral of the title of full Professor. Research in the Swietach Lab is driven by an interest in how biological processes are affected by chemical acidity.
\n \n\n \n \n27 October 2020
\n \n \n \nCongratulations are in order for Associate Professor Samira Lakhal-Littleton, who has been awarded a Senior Non-Clinical Fellowship by the Medical Research Council to further her lab's work exploring the implications of the cardiac hepcidin/ferroportin axis for the management of iron deficiency in heart failure.
\n \n\n \n \n19 October 2020
\n \n \n \n\n \n \n19 October 2020
\n \n \n \n\n \n \n11 October 2020
\n \n \n \nProfessor Paul Riley will lead the scientific vision of the first institute of its kind in the world to physically merge the disciplines of developmental biology and regenerative medicine in a common goal to treat some of the world\u2019s most prolific diseases.
\n \n\n \n \n4 September 2020
\n \n \n \nThe partnership will produce the first ever British Society of Echocardiography National review of Stress Echocardiography Practice (BSE N-STEP).
\n \n\n \n \n4 September 2020
\n \n \n \nA new paper from the Heather and Tyler groups has uncovered the mechanism responsible for reduced energy in the hearts of patients with type 2 diabetes and revealed a new therapeutic strategy to reverse the energy deficit.
\n \n\n \n \n24 July 2020
\n \n \n \nResearchers at the Nuffield Department of Population Health, in collaboration with other researchers, have published new findings that identify a combination of factors that put some patients at higher risk of myopathy.
\n \n\n \n \n15 July 2020
\n \n \n \nThe number of admissions to hospital with heart attacks fell by 35% by the end of March.
\n \n\n \n \n14 July 2020
\n \n \n \n\n \n \n13 July 2020
\n \n \n \n\n \n \n8 July 2020
\n \n \n \n\n \n \n26 May 2020
\n \n \n \nDPAG researchers have collaborated on an international study that demonstrates a detailed mechanistic understanding of how the anti-malaria drug, Hydroxychloroquine, combined with antibiotics, can cause adverse cardiac side-effects in COVID-19 patients. This gives weight to US Federal advice against using this combined treatment.
\n \n\n \n \n14 May 2020
\n \n \n \n\n \n \n29 April 2020
\n \n \n \nDPAG's Associate Professor Mathilda Mommersteeg and Professor Paul Riley, in collaboration with Professor Robin Choudhury from the Radcliffe Department of Medicine, will perform single cell analysis of inflammation during heart regeneration with a grant from the Chan Zuckerberg Initiative.
\n \n\n \n \n27 April 2020
\n \n \n \nNew collaborative research from the Mommersteeg Group and MRC WIMM researchers shows that a protein called Runx1 plays a significant role in the formation of the cardiac scar that forms after the heart is injured, a scar that is known to inhibit heart regeneration. In the zebrafish, a freshwater fish known to be able to fully regenerate its heart after damage, they show that the absence of Runx1 results in enhanced regeneration. This indicates a potential new therapeutic target for heart repair.
\n \n\n \n \n6 February 2020
\n \n \n \n\n \n \n